Real-world Effectiveness and Safety of Direct-acting Antiviral Agents in Patients with Chronic Hepatitis C Genotype 2 Infection: Korean Multicenter Study

BACKGROUND: The advancement of treatment with direct-acting antiviral (DAA) agents has improved the cure rate of hepatitis C virus (HCV) infection close to 100%. The aim of our study was to assess the real-world effectiveness and safety of DAA regimens for the treatment of patients with chronic HCV...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Yeo Wool, Baek, Yang Hyun, Lee, Sung Wook, Park, Sung-Jae, Yoon, Jun Sik, Yoon, Ki Tae, Hong, Youngmi, Heo, Nae-Yun, Seo, Kwang Il, Lee, Sang Soo, Cho, Hyun Chin, Shin, Jung Woo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167412/
https://www.ncbi.nlm.nih.gov/pubmed/34060258
http://dx.doi.org/10.3346/jkms.2021.36.e142

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167412/
https://www.ncbi.nlm.nih.gov/pubmed/34060258
http://dx.doi.org/10.3346/jkms.2021.36.e142

Ejemplares similares